Thrombosis, prevalence and new evidence on current perceptions of risk

Herbert M. Pinedo

Research output: Contribution to journalArticlepeer-review

Abstract

Venous thromboembolism is a significant but unquantified clinical problem in patients with cancer. The FRONTLINE survey was designed to evaluate clinicians' perceptions of thrombosis risk for cancer patients and to examine current clinical practice with regard to thromboprophylaxis and treatment of venous thromboembolism. Over 3800 responses from surgeons, haematologists and other clinicians were received. Their perception of thrombosis risk for patients varied according to the site of primary tumour. Most surgeons thought that patients with brain tumours were at high risk of thrombosis. Most clinicians treating medical (non-surgical) cancer patients perceived pancreatic tumours to carry a high thrombosis risk in the absence of thromboprophylaxis.

Original languageEnglish (US)
Pages (from-to)3-5
Number of pages3
JournalCancer Treatment Reviews
Volume29
Issue numberSUPPL. 2
StatePublished - Jun 2003
Externally publishedYes

Keywords

  • Cancer patients
  • Clinician survey
  • Thrombosis risk
  • Venous thromboembolism

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Thrombosis, prevalence and new evidence on current perceptions of risk'. Together they form a unique fingerprint.

Cite this